RayKnowChina Research Map
Shortlist0

RecruitingStomach cancerN/A

Registered title, quoted from ClinicalTrials.gov

OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method

An open trial on stomach cancer, registered on ClinicalTrials.gov. Led by Nanfang Hospital; 7 other hospitals on this site are listed as study sites.

Status, phase and start date as registered on ClinicalTrials.gov on 8 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.

The study team’s contact details are on the registry record. This site does not pass on enquiries.

Checklist for this trial 5

Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.

Show the checklist (5 points)Hide the checklist
  1. 18 years to 75 years; sex: all

    Registered eligibility fields

  2. Primary lesion is pathologically diagnosed as gastric adenocarcinoma;

    Inclusion criterion 2

  3. Confirmed stage IV (AJCC 8th) during surgery

    Exclusion criterion 4

  4. Preoperative performance status (ECOG, Eastern Cooperative Oncology Group) of 0 or 1;

    Inclusion criterion 6

  5. Women during pregnancy or breast-feeding;

    Exclusion criterion 1

Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: earlier treatment; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes.

Questions to ask the study team

Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT05450835, read on 10 Nov 2026.

Registered criteria

Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.

Inclusion Criteria:

  • Aged 18-75 years;
  • Primary lesion is pathologically diagnosed as gastric adenocarcinoma;
  • Expected to live more than 1 year;
  • Tumor located located in gastroesophageal junction (GEJ) involve esophagus no more than 2cm, or in the upper, upper to middle, or entire stomach, and intend to perform laparoscopic total gastrectomy with D2 lymphadenectomy
  • No history of upper abdominal surgery (except for laparoscopic cholecystectomy);
  • Preoperative performance status (ECOG, Eastern Cooperative Oncology Group) of 0 or 1;
  • Preoperative ASA (American Society of Anesthesiologists) scoring: I-III;
  • Without preoperative radiotherapy;
  • Did not found metastasis preoperatively and intraoperatively;
  • Sufficient organ functions;
  • Written informed consent.

Exclusion Criteria:

  • Women during pregnancy or breast-feeding;
  • Body temperature ≥ 38 °C before surgery or infectious disease with a systemic therapy indicated;
  • Severe mental disease;
  • Confirmed stage IV (AJCC 8th) during surgery
  • Severe respiratory disease;
  • Severe hepatic and renal dysfunction;
  • Unstable angina pectoris or history of myocardial infarction within 6 months;
  • History of cerebral infarction or cerebral hemorrhage within 6 months;
  • Gastric cancer complications (bleeding, perforation, obstruction) that requiring emergency surgery;
  • Performing hyperthermic intraperitoneal chemotherapy (HIPEC) after surgery.

Quoted from ClinicalTrials.gov, NCT05450835, participation criteria. Read on 10 Nov 2026.

Where this information comes from

The registry record

ClinicalTrials.gov (US National Library of Medicine), record NCT05450835, read on 8 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.

Diseases and hospitals

The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions

What is left out

Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.

Suggest a correctionClinicalTrials.gov NCT05450835